Earnings History Data for Lantern Pharma Inc. (LTRN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Lantern Pharma Inc.
Lantern Pharma Inc.is a biotechnology company. It develops medicines for multi-drug treatment resistance cancers focusing on prostate and ovarian cancers. The company's drug candidate consist LP-100, LP-300 and LP-184 which are in clinical stage. Lantern Pharma Inc.is based in Dallas, Texas.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | AH | LTRN | Lantern Pharma Inc. | 35.20 | -0.42 | -0.56 | -0.29 | 3.77 | 0.35 (10.09%) |
3.38 | -0.04 (-1.17%) |
2.74 - 11.99 | 46,491 | 40,000 | 2,380 | |||
| 08-08-2024 | PM | LTRN | Lantern Pharma Inc. | 38.62 | -0.46 | -0.55 | -0.44 | Lantern Pharma GAAP EPS of -$0.46 beats by $0.09 [8/9/2024 1:58 AM] |
3.90 | -0.33 (-7.68%) |
4.37 | 0.14 (3.31%) |
2.38 - 11.99 | 90,495 | 60,000 | 663 | ||
| 09-05-2024 | AH | LTRN | Lantern Pharma Inc. | 68.96 | -0.51 | -0.43 | -0.36 | Lantern Pharma GAAP EPS of -$0.51 misses by $0.08 [5/9/2024 4:43 PM] |
6.18 | -0.63 (-9.25%) |
6.38 | -0.43 (-6.31%) |
2.38 - 11.99 | 230,419 | 150,000 | 1,414 | ||
| 18-03-2024 | AH | LTRN | Lantern Pharma Inc. | 79.89 | -0.39 | -0.40 | -0.31 | Lantern Pharma GAAP EPS of -$0.39 beats by $0.01 [3/18/2024 4:08 PM] |
7.48 | -2.48 (-24.90%) |
9.20 | -0.76 (-7.63%) |
2.38 - 10.73 | 943,830 | 880,000 | 18,317 | ||
| 08-11-2023 | AH | LTRN | Lantern Pharma Inc. | 32.06 | -0.29 | -0.46 | -0.21 | Lantern Pharma GAAP EPS of -$0.29 [11/8/2023 4:03 PM] |
3.79 | 0.99 (35.36%) |
0.0 | 0.0 (0.00%) |
2.38 - 6.20 | 441,286 | 30,000 | 0 | ||
| 09-08-2023 | AH | LTRN | Lantern Pharma Inc. | 50.49 | -0.44 | -0.40 | -0.41 | Lantern Pharma GAAP EPS of -$0.44 misses by $0.01 [8/9/2023 5:15 PM] |
4.89 | 0.22 (4.71%) |
4.99 | 0.32 (6.85%) |
4.05 - 6.59 | 92,209 | 30,000 | 11,188 | ||
| 09-05-2023 | AH | 4:00 PM ET (May 9) |
LTRN | Lantern Pharma Inc. | 54.39 | -0.36 | 0.00 | -0.38 | Lantern Pharma GAAP EPS of -$0.36 beats by $0.12 [5/9/2023 4:16 PM] |
5.51 | -0.09 (-1.61%) |
0.0 | 0.0 (0.00%) |
4.05 - 6.59 | 20,001 | 20,000 | 0 | |
| 20-03-2023 | AH | 4:00 PM ET (Mar 20) |
LTRN | Lantern Pharma Inc. | 57.54 | -0.31 | -0.49 | -0.31 | Lantern Pharma GAAP EPS of -$0.31 beats by $0.16 [3/20/2023 4:04 PM] |
4.45 | -0.20 (-4.30%) |
5.05 | 0.40 (8.60%) |
4.05 - 7.92 | 37,986 | 50,000 | 1,746 | |
| 07-11-2022 | AH | 4:00 PM ET (Nov 7) |
LTRN | Lantern Pharma Inc. | 47.98 | -0.21 | -0.54 | -0.36 | Lantern Pharma GAAP EPS of -$0.21 beats by $0.27 [11/7/2022 4:05 PM] |
4.39 | -0.08 (-1.79%) |
4.38 | -0.09 (-2.01%) |
4.19 - 10.44 | 359,251 | 30,000 | 702,301 | |
| 08-08-2022 | AH | LTRN | Lantern Pharma Inc. | 54.70 | -0.41 | -0.52 | -0.21 | Lantern Pharma GAAP EPS of -$0.41 beats by $0.11 [8/8/2022 4:47 PM] |
5.60 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
4.76 - 14.82 | 20,038 | 20,000 | 0 | ||
| 03-05-2022 | AH | 4:05 PM ET (May 3) |
LTRN | Lantern Pharma Inc. | 64.82 | -0.38 | 0.00 | -0.24 | Lantern Pharma GAAP EPS of -$0.38 [5/3/2022 4:37 PM] |
6.36 | 0.30 (4.95%) |
6.01 | -0.05 (-0.83%) |
5.45 - 16.50 | 8,991 | 20,000 | 200 | |
| 10-03-2022 | AH | 4:05 PM ET (Mar 10) |
LTRN | Lantern Pharma Inc. | 64.95 | -0.31 | -0.40 | -0.47 | Lantern Pharma GAAP EPS of -$1.13 misses by $0.74 [3/10/2022 4:26 PM] |
6.83 | 0.28 (4.27%) |
7.25 | 0.70 (10.69%) |
5.45 - 23.50 | 22,629 | 40,000 | 1,320 | |
| 01-11-2021 | AH | 4:00 PM ET (Nov 1) |
LTRN | Lantern Pharma Inc. | 115.64 | -0.36 | -0.27 | -0.27 | Lantern Pharma EPS misses by $0.09 [11/1/2021 4:57 PM] |
10.05 | -0.05 (-0.50%) |
10.18 | 0.08 (0.79%) |
9.00 - 23.50 | 115,530 | 50,000 | 4,999 | |
|
||||||||||||||||||
| 29-07-2021 | AH | 4:30 PM ET (Jul 29) |
LTRN | Lantern Pharma Inc. | 140.66 | -0.21 | -0.25 | -0.31 | Lantern Pharma EPS beats by $0.04 [7/29/2021 4:44 PM] |
12.91 | -0.06 (-0.46%) |
13.17 | 0.26 (2.01%) |
10.40 - 24.84 | 61,627 | 90,000 | 3 | |
| 03-05-2021 | AH | 4:00 PM ET (May 3) |
LTRN | Lantern Pharma Inc. | 176.78 | -0.24 | -0.26 | 0.00 | Lantern Pharma reports Q1 results [5/3/2021 4:40 PM] |
15.60 | -0.38 (-2.38%) |
15.90 | 0.89 (5.93%) |
10.40 - 24.84 | 57,040 | 110,000 | 671 | |
|
||||||||||||||||||
| 10-03-2021 | AH | After the close (Mar 10) |
LTRN | Lantern Pharma Inc. | 164.29 | -0.47 | -0.47 | 0.00 | Lantern Pharma EPS misses by $0.02 [3/10/2021 4:44 PM] |
18.43 | 1.78 (10.71%) |
15.98 | 0.0 (0.00%) |
10.40 - 24.84 | 116,109 | 160,974 | 365 | |
|
||||||||||||||||||
| 29-10-2020 | AH | After the close (Oct 29) |
LTRN | Lantern Pharma Inc. | 103.21 | -0.27 | -0.33 | 0.00 | Lantern Pharma EPS beats by $0.56 [10/29/2020 4:02 PM] |
15.10 | -0.15 (-0.98%) |
15.25 | 0.08 (0.53%) |
10.40 - 24.84 | 32,119 | 26,830 | 354 | |
|
|
||||||||||||||||||